GeneralConnection.com ➔ Dictionary
Dictionary Search

tardive dyskinesia

Synonyms

Noun

1. dyskinesia

Usage
Spotlight on the Psychosocial Impact of Tardive Dyskinesia - Psychiatry Advisor
Masking and Unmasking in Tardive Dyskinesia - Pharmacy Practice News
Tardive Dyskinesia in Older Adults: Identification and Management in Long-Term Care Settings - Psychiatric Times
Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea - NeurologyLive
Clinical practice guidelines for the treatment of tardive dyskinesia in Europe: A descriptive review - Cambridge University Press & Assessment
Detecting Tardive Dyskinesia Using Video-Based Artificial Intelligence - Psychiatrist.com
Risperdal (Risperidone) Side Effects: Common and Rare - Verywell Mind
This condition affects at least 5% of people who take antipsychotic medication - Health: Trusted and Empathetic Health and Wellness Information
Distinguishing Tardive Dyskinesia From Other Movement Disorders - HMP Global Learning Network
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1065890 in Adults with Tardive Dyskinesia - PR Newswire
5 Rules to Better Tardive Dyskinesia Management - HealthCentral
EMA Says Active Substance in Tardive Dyskinesia Drug Not New - Medscape
Building a Tardive Dyskinesia Center of Excellence: A Multidisciplinary Model - Pharmacy Practice News
Valbenazine Linked to Better Physical and Emotional Well-Being in Tardive Dyskinesia - NeurologyLive
New Review on VMAT2 Inhibitors and Ingrezza for Treatment of Tardive Dyskinesia - Psychiatric Times
Neurocrine Biosciences Presents New Post-Hoc Analysis: Treatment with INGREZZA® (valbenazine) Capsules Achieves Earlier Remission of Tardive Dyskinesia Symptoms While Reducing Patient-Reported Disease Burden - PR Newswire
Managing Tardive Dyskinesia (Part 2) - Pharmacy Practice News
VMAT2 Inhibitor NBI-1065890 Heads to Phase 2 Study in Tardive Dyskinesia - NeurologyLive
Well-Rounded Examination for Treatment of Tardive Dyskinesia - Psychiatric Times
Accurate Diagnosis of Tardive Dyskinesia Is Critical to Optimal Outcomes - Pharmacy Practice News
Austedo Phase 4 Data Shows Reduction in Tardive Dyskinesia Severity - Psychiatric Times
Teva drafts NFL star Terrell Davis for tardive dyskinesia awareness drive - Fierce Pharma
Patient Awareness of Tardive Dyskinesia: Insights From Cherian Karunapuzha, MD - Psychiatric Times
Risk Factors of Tardive Dyskinesia - Pharmacy Times
How to Talk About Tardive Dyskinesia with A Doctor - Healthgrades Health Library
Real-world data shows AUSTEDO improves life for patients with tardive dyskinesia - PharmaTimes
Distinguishing Tardive Dyskinesia From Other Drug-Induced Movement Disorders - Pharmacy Practice News
New Post-Hoc Analysis: Treatment With Ingrezza Results in Earlier Remission of Tardive Dyskinesia Symptoms and Reduced Disease Burden - Psychiatric Times
Mitigating the Risk For Tardive Dyskinesia in Elderly Patients on Antipsychotics - MedPage Today
Tardive Dyskinesia: Spotlight on Current Approaches to Treatment - Psychiatry Online
AI Tool Shows Promise for Improving Early Detection of Tardive Dyskinesia - Physician's Weekly
Tardive Dyskinesia's Impact on Quality of Life - MedPage Today
VMAT-2 Inhibitor Differences and Dosing in Tardive Dyskinesia - HMP Global Learning Network
Most Tardive Dyskinesia Cases Go Undiagnosed, Real-World Study Finds - Pharmacy Practice News
What’s New in Tardive Dyskinesia, With Jonathan Meyer, MD - HCPLive
Phase 2 Study Initiated for NBI-1065890 to Treat Tardive Dyskinesia - Psychiatric Times
Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score - Psychiatric Times
How VMAT2 Inhibitors Are Reshaping Tardive Dyskinesia Care - Pharmacy Practice News
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical Practice - Pharmacy Times
Diagnostic Challenges in Distinguishing Huntington Disease From Tardive Dyskinesia - Psychiatrist.com
New Post-Hoc Analysis: Ingrezza 40 mg Leads to Clinically Meaningful Improvements in Tardive Dyskinesia Symptoms - Psychiatric Times
Tardive Dyskinesia Management Gaps in LongTerm Care - Pharmacy Practice News
Monitoring for Tardive Dyskinesia: Who Is at Greatest Risk? - Physician's Weekly
Teva Kicks Off ‘The Other TD’ to Raise Awareness of Tardive Dyskinesia (TD), with Support from Pro Football Hall of Famer Terrell Davis - Yahoo Finance
Assessing Tardive Dyskinesia: AIMS and the Clinician’s Tardive Inventory - Pharmacy Practice News
Sustained Benefits of Long-Term VMAT2 Inhibitor Therapy in Tardive Dyskinesia - Pharmacy Times
Neurocrine’s Next VMAT2 Study Adds Depth To Tardive Dyskinesia Story - Yahoo Finance
Acute exacerbation of major depressive disorder following valbenazine treatment for tardive dyskinesia: A case report - Wiley Online Library
Neurocrine Biosciences Announces New Survey Revealing Need for Routine Screening and Earlier Diagnosis for People Living with Tardive Dyskinesia - PR Newswire
Digital Tools to Detect Tardive Dyskinesia - MedPage Today
Caregiving Guide for Helping to Manage Tardive Dyskinesia - HealthCentral
A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation - Nature
Assessing Neurocrine Biosciences (NBIX) Valuation After New Phase 2 VMAT2 Tardive Dyskinesia Trial Launch - Yahoo Finance
9 Questions to Ask Your Doctor About Taking VMAT2 Inhibitors for TD - HealthCentral
Neurocrine Biosciences Presents Patient-Reported Outcomes from KINECT-PRO™ Study Demonstrating INGREZZA® (valbenazine) Capsules Improved Functionality and Quality of Life in Patients with Tardive Dyskinesia - PR Newswire
Neurocrine Biosciences Presents New Data Showing Significant Patient-Reported Improvements in Health-Related Quality of Life with INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia - PR Newswire
The Role of Ultrasound in Diagnosing Tardive Dyskinesia: A New Frontier in Movement Disorders - Physician's Weekly
Neurocrine Biosciences and Carnie Wilson Team Up to Launch ConnectING with Carnie™ Awareness Campaign for People with Tardive Dyskinesia - PR Newswire
Deep Brain Stimulation for Tardive Dyskinesia - MedPage Today
Neurocrine Biosciences Presents Data Adding to the Growing Body of Evidence Demonstrating Functional and Quality of Life Improvements in Patients with Tardive Dyskinesia - PR Newswire
Rapid-onset tardive dyskinesia–like disorder after a single dose of haloperidol - CMAJ
Understanding the Impact of Tardive Dyskinesia Across Patient Populations - Pharmacy Times
Vesicular monoamine transport inhibitors: current uses and future directions - The Lancet
Haloperidol Induced Orofacial Dyskinesia: Clinical Insights Into Buccolingual Masticatory Syndrome - Wiley Online Library
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR - PR Newswire
Supplements for Tardive Dyskinesia - Healthgrades Health Library
Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules - PR Newswire
A Choice and a Voice: Supporting Patient-Centered Decisions in Tardive Dyskinesia Care - Medscape
ICD-Confirmed Tardive Dyskinesia Diagnosis Seen in Only 5% of Suspected Cases - Physician's Weekly
Neurocrine holds on to branded tardive dyskinesia push with help from Wilson Phillips star - Fierce Pharma
Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry - PR Newswire
Teva Pharmaceuticals Reports Positive Real-World Data on AUSTEDO and AUSTEDO XR for Tardive Dyskinesia Treatment in IMPACT-TD Registry - Quiver Quantitative
Neurocrine Biosciences Presents New KINECT® 4 Post-Hoc Analysis Demonstrating Rapid and Sustained Therapeutic Efficacy of INGREZZA® (valbenazine) 40 mg Capsules - PR Newswire
Patient Perspectives on Barriers to Diagnosis and Treatment of Tardive Dyskinesia from a Cross-sectional Survey (P4-5.018) - Neurology® Journals
Valbenazine Safe and Effective for Long-Term Treatment of Tardive Dyskinesia in Elders - NeurologyLive
Neurocrine’s New Tardive Dyskinesia Trial And What It Means For Valuation - Sahm
Working with Tardive Dyskinesia: Requesting Accommodations - Healthline
Pro Football Hall of Famer Terrell Davis, Teva call attention to ‘The Other TD’ - Medical Marketing and Media
Your Questions, Answered, on Tardive Dyskinesia - HealthCentral
Why Singer Carnie Wilson Is Raising Awareness Of Tardive Dyskinesia - Forbes
Which Treatment for Tardive Dyskinesia Is Right for You? - HealthCentral
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy - PR Newswire
Improvements Over Time with Valbenazine in Elderly Adults (≥65 Years) with Tardive Dyskinesia: Post Hoc Analyses of 2 Long-Term Studies - Psychiatrist.com
Valbenazine Improves Tardive Dyskinesia in Older Adults Over Long Term | Psychiatric News - Psychiatry Online
Neurocrine Biosciences Presents Real-World Data on Therapeutic Dose Attainment and Dosing Trends of VMAT2 Inhibitors in Patients With Tardive Dyskinesia - PR Newswire
How to Improve the Symptoms of Tardive Dyskinesia - HealthCentral
Teva Taps Terrell (TD) Davis To Combat 'The Other TD' (Tardive Dyskinesia) 11/11/2025 - MediaPost
Neurocrine initiates phase 2 study for tardive dyskinesia treatment - Investing.com
Antipsychotics and Tardive Dyskinesia: What’s the Connection? - HealthCentral
Neurocrine Biosciences Presents 48-Week Remission Data on Treatment of Tardive Dyskinesia With INGREZZA® (valbenazine) Capsules - PR Newswire
How the Search for Genes Involved in Mental Illness Has Led to Key Insights About Reducing Medication Side Effects - Brain and Behavior Research
Neurocrine's VMAT2 inhibitor fails in pivotal dyskinetic cerebral palsy study - FirstWord Pharma
Awareness of Multiple Treatment Options for Tardive Dyskinesia: Tips from Dr Jonathan Meyer - Psychiatric Times
Perspectives in Psychopharmacology - Psychiatry Online
Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Established Safety Profile of INGREZZA® (valbenazine) Capsules for Huntington's Disease Chorea - PR Newswire
New Ingrezza Data Demonstrates Functional and Quality of Life Improvements in Patients With Tardive Dyskinesia - Psychiatric Times
Tardive Dyskinesia Treatment Market Size, Share | CAGR Of 6.3% - Market.us
Neurocrine leans on singer Carnie Wilson for tardive dyskinesia push - Medical Marketing and Media
Teva Pharmaceutical Industries Shares Positive Patient Survey Results for AUSTEDO XR® in Tardive Dyskinesia Treatment - Quiver Quantitative
Neurocrine's Ingrezza fails phase 3 trial for cerebral palsy - Fierce Pharma
Foreign Language Equivalents
Foreign Language Equivalents of 'tardive dyskinesia'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
taardive dyskinesia,   tardive dyskimesia,   tardive syskinesia,   tardive dysinesia,   tardvie dyskinesia,   tardive dyskinesai,   tardive dyskinrsia,   tarfive dyskinesia,   tsrdive dyskinesia,   tardice dyskinesia,   tardove dyskinesia,   tardve dyskinesia,   tardive ydskinesia,   tardiive dyskinesia,   tardibe dyskinesia,   tardived yskinesia,   tardive dyskinessia,   tardive dyskniesia,   tardive dyskiesia,   tardiev dyskinesia,   tardive dyslinesia,   tardive dyksinesia,   tardivve dyskinesia,   tardive dyskinesua,   tardive dyskunesia,   tardive dyskinesoa,   tradive dyskinesia,   tardive dyskinesia,   tardive dysjinesia,   tardive duskinesia,   tardive dyskineisa,   tarive dyskinesia,   tardive dysskinesia,   tarduve dyskinesia,   tardive dtskinesia,   tardive dyskkinesia,   atrdive dyskinesia,   tardive dydkinesia,   tardive dykinesia,   tardive yskinesia,   rardive dyskinesia,   tardive dyskineaia,   tarddive dyskinesia,   taedive dyskinesia,   tardive dskinesia,   tardive dyskinesi,   tardive dysknesia,   tardive dyskibesia,   tardive dyskiinesia,   tadive dyskinesia,   yardive dyskinesia,   tardive dyskinnesia,   tarrdive dyskinesia,   tardivedyskinesia,   tardive dyakinesia,   tardive dyskinwsia,   tardive dyskonesia,   tardive dyskinsia,   ttardive dyskinesia,   tatdive dyskinesia,   tardive dyskinedia,   tardive ddyskinesia,   tardive dyyskinesia,   tarsive dyskinesia,   tardive dysiknesia,   tadrive dyskinesia,   tardive dyskinesiaa,   tardive dyskineia,   tardiv edyskinesia,   tardiv dyskinesia,   ardive dyskinesia,   trdive dyskinesia,   tardive dyskinesis,   tardive fyskinesia,   tardive dyskinesa,   tardivw dyskinesia,   tardive dyskinseia,   tardive dyskineesia,   tardivee dyskinesia,   tardive dsykinesia,   tardivr dyskinesia,   tardive dyskinesiia,   tardive dyskiensia,   tardie dyskinesia,   taridve dyskinesia
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z